Linical Co., Ltd. Price (2183.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

22,586,436

(0)%

Linical Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research se... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $323-463
  • Market Cap 7.61B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Kazuhiro Hatano
  • IPO Date: October, 27, 2008
  • Country: JP
  • Currency: JPY
  • Headquaters: No Data
  • Employees: 662

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation